Page last updated: 2024-10-22

amoxapine and Catatonia

amoxapine has been researched along with Catatonia in 1 studies

Amoxapine: The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both; it also blocks dopamine receptors. Amoxapine is used for the treatment of depression.
amoxapine : A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.

Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)

Research Excerpts

ExcerptRelevanceReference
"The case of a patient who developed the neuroleptic malignant syndrome following an overdose of amoxapine is presented."7.67Neuroleptic malignant syndrome following amoxapine overdose. ( Schwartz, HI; Taylor, NE, 1988)
"The case of a patient who developed the neuroleptic malignant syndrome following an overdose of amoxapine is presented."3.67Neuroleptic malignant syndrome following amoxapine overdose. ( Schwartz, HI; Taylor, NE, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taylor, NE1
Schwartz, HI1

Other Studies

1 other study available for amoxapine and Catatonia

ArticleYear
Neuroleptic malignant syndrome following amoxapine overdose.
    The Journal of nervous and mental disease, 1988, Volume: 176, Issue:4

    Topics: Adult; Amoxapine; Basal Ganglia Diseases; Catatonia; Diagnosis, Differential; Dibenzoxazepines; Fema

1988